22/03/2020 by By digital
Repair of a complete anterior cruciate tear using prolotherapy: a case report
Surgical reconstruction is considered definitive treatment for anterior cruciate ligament (ACL) tears but precise surgical indications are debated. Some patients are reluctant or inappropriate surgical candidates. Prolotherapy is a non-surgical injection therapy for chronic musculoskeletal pain and instability. This case report documents the non-surgical repair of a torn ACL using prolotherapy and at-home exercise.
Repair of a complete anterior cruciate tear using prolotherapy: a case report
The patient declined surgical treatment. Due to ongoing right knee symptoms, she was then assessed, at 18 weeks post-injury, in a musculoskeletal medicine clinic by the lead author (WG). At that time, although she did not report a significant resting knee pain, the knee dysfunction did not allow her to perform normal activities of daily living, and buckled frequently with weight-bearing. She reported ambulating poorly without crutches and not being able to walk up or down stairs without support. Physical exam revealed more than 1 cm of laxity on the right anterior drawer test compared to minimal laxity on the left, and a significantly positive Lachman’s test, consistent with a complete ACL tear with soft or no endpoint.
Past medical and surgical histories were non-contributory.
Injection and Exercise Therapy
With the exception of treatment sessions 4 and 5, at which times pain may have been associated with increased activity, the patient reported generally diminished symptoms and improved function over the course of the injection sessions.
At 32 weeks post-injury (12 weeks after initiation of prolotherapy), the patient’s function was much improved; she was able to walk, and climb and descend stairs independently without instability. She felt increased knee strength, and reported being back to 80% of baseline. She was able to perform 3 sets of 8 repetitions of leg extensions with 7 lb-weights, and started biking 30 minutes per day.
At 37 weeks post-injury (15 weeks after initiation of prolotherapy), her anterior drawer test was normal and symmetrical to that of the left knee. She returned to independent ambulation, bicycling and jogging, and was very satisfied with her care. Her post-treatment MRI showed a well-healed, relatively homogeneous ACL. Only minimal irregularity and heterogeneity were seen in the midportion of ACL at the location of prior injury. No anterior drawer sign or bone contusion were noted. The MRI was interpreted as compatible with a healing, chronic near-complete or complete ACL tear.
This case report documents the successful non-surgical repair of an MRI-confirmed high grade or total ACL tear in an 18 year old female with knee laxity and instability using prolotherapy and at-home exercise. After treatment, the patient regained full knee function, resumed normal activity and returned to recreational sport. Post-treatment MRI revealed a healing chronic ACL tear. These findings are notable given that surgical ACL reconstruction is the conventional treatment for ACL tears with such clinical presentation.
This case is consistent with another published case reporting the repair of a completely ruptured Achilles tendon(17) using prolotherapy. In this report, a 26 year old female athlete with an MRI-and ultrasound-documented Achilles tendon rupture experienced excellent clinical improvement with a 14-week course of 8 prolotherapy sessions using dextrose and morrhuate sodium and at-home isometric exercises. The author reported that post-treatment MRI and ultrasound revealed an intact, slightly atrophic, chronically injured Achilles tendon. A subsequent letter to the editor regarding this case, however, contended that the images provided did not support the description of the injured state of the tendon, casting doubt on the modification of inured tissue by prolotherapy reported by the author. Reeves et al. have also reported positive effects of prolotherapy on injured ACLs. (18) Subjects with knee osteoarthritis, and knee pain with ACL laxity were found to have slightly decreased laxity 12 months after prolotherapy. However, no subjects had significant ACL injury, limiting comparison to the current report.
While no rigorous clinical trials have assessed prolotherapy as a treatment for ligamentous tears, 4 recent studies of prolotherapy for severe overuse tendinopathies(14–16) have reported positive findings. Subjects with severe lateral epicondylosis treated with morrhuate sodium and dextrose prolotherapy experienced 68% pain reduction and improved isometric strength compared to control saline injections (p<0.05) at 16 weeks post-treatment.(15) Subjects with chronic symptomatic Achilles tendinopathy have been evaluated in a strong pilot level RCT and prospective case series. In Yelland et al.,(19) 40 subjects with painful mid-portion Achilles tendinosis received eccentric exercise, prolotherapy injections, or combined treatment. Combined treatment resulted in significantly better clinical and financial outcomes. In Maxwell et al., subjects received ultrasound-guided dextrose prolotherapy and, at 6 weeks post-treatment, reported a reduction of pain by 80–90% during rest, light activity and sports, and showed improved ultrasound findings.(14) Elite male athletes with chronic adductor groin pain and inability to play soccer or rugby received dextrose prolotherapy and reported a 78% improvement in pain with activity; 83% of these subjects reported a complete resolution of pain and 92% were able to return to unrestricted sport activity.(16)
The mechanism by which prolotherapy may influence soft tissue healing is not known. Connective tissue often heals poorly due to limited vascular supply. Prolotherapy is hypothesized to stimulate an auto-regulatory immune response leading to the reestablishment of structural integrity, improved function and pain relief.(9) Animal model studies have reported significant biological effects for prolotherapy injections with both dextrose (an irritant)(20) and morrhuate sodium (a vascular sclerosant).(21, 22, 23) Pumice suspension and phenol-quinine-urea solution have not been rigorously evaluated in animal or human studies, though they are in limited use in the prolotherapy community. Both are thought to be irritants; pumice is hypothesized to attract macrophages, while phenol-quinine-urea is hypothesized to directly alkylate proteins on the surfaces of cells. In either case, granulocytes and macrophages are attracted to the injection site and the wound healing cascade is initiated.(24) Prolotherapy is one of several injection therapies that may initiate a regenerative response in chronically injured soft tissue. A recent systematic review suggested that injections with polidocanol, whole blood and platelet rich plasma may each also confer this effect compared to control injections.(25)
While prolotherapy may have played a role in this patient’s clinical recovery and the improvement in the appearance of her MRI, several caveats prevent the conclusion that prolotherapy alone was responsible. 1) While MRI is the diagnostic imaging technique of choice, it is not perfect. A recent systematic review reported it’s overall sensitivity and specificity for ACL injury to be 86.5% and 95.2% respectively.(26) The tear may have therefore have been near-complete, or the severed ends of the ligament may have been in close enough approximation to facilitate natural healing. On the other hand, the presence of subchondral bone contusions have been reported to be significantly more associated with complete ACL ruptures than with incomplete tears.(27) 2) The Lachman test also is not perfect. Overall sensitivity and specificity for ACL tear have been reported to be 86% and 91% respectively,(28) though two other examiners in this case (at initial accident and in Orthopedic consultation) concurred on the likelihood of at least a high-grade tear. In addition, parts of the clinical exam, including knee buckling are consistent with other conditions such as patellofemoral knee pain. 3)The post-treatment ligament is not completely normal; the degree of fibrosis might conceivably be found on an untreated ACL in response to time and physiotherapy. Other limitations include the lack of an early supervised ACL rehabilitation program and the lack of independent confirmation of physical exam results.
This case report is strengthened by description of the pragmatic use of prolotherapy by a physician specializing in musculoskeletal medicine and experienced in injection medicine who tailored therapy specifically to this patient and her clinical progress over time. Prior clinical trials have used fixed solution recipes and injection schedules which do not allow responsiveness to individual clinical change. The components of the solutions injected and timing of injections used in this case reflect a common practice pattern within the clinical prolotherapy community; solutions used early in a treatment course (dextrose, morrhuate sodium) are perceived to be less ‘strong’ than those used later in the treatment course (phenol-quinine-urea, pumice). However, the complexity of the regimen limits its incorporation into routine practice. The relative effectiveness of prolotherapy solutions compared to one another has not been compared in any clinical trial.
The limitations above prevent a categorical conclusion that prolotherapy alone contributed to or restored pain-free function and improved the appearance of the MRI. However, the facts of this case and the context provided by prior clinical trials suggest that prolotherapy at least augmented the healing a high grade or total ACL tear. These findings further suggest that prolotherapy may be an alternative treatment to surgery for carefully selected patients and should be assessed as a treatment of ligamentous tears, especially in patients who are unwilling or unable to undergo surgical intervention.
Walter Grote, Sparta Medical Associates, Columbia NJ, 07832.
Rosa Delucia, University of Wisconsin Department of Family Medicine, 777 S. Mills St, Madison WI, 53715.
Robert Waxman, Diagnostic Radiology Associates, PA, Clifton, NJ 07013.
Aleksandra Zgierska, University of Wisconsin Department of Family Medicine, 777 S. Mills St, Madison WI, 53715.
John Wilson, University of Wisconsin Department of Family Medicine, 777 S. Mills St, Madison WI, 53715.
David Rabago, University of Wisconsin Department of Family Medicine, 777 S. Mills St, Madison WI, 53715.
- Johnson RJ, Beynnon BD, Nichols CE, Renstrom PA. The treatment of injuries of the anterior cruciate ligament. J Bone Joint Surg Am. 1992;74:140–151. [PubMed]
- Griffen L, Agel J, Albohm MJ, Arendt EA, Dick RW, Garrett WE, et al. Noncontact ACL injuries: risk factors and prevention strategies. J Am Acad Orthop Surg. 2000;8:141–150. [PubMed]
- Shuterback S. The incidence of ACL tears in men and women collegiate soccer players. Ortho Trans. 1996;20:259.
- Engstrom B, Gornitzka J, Johansson C, Wredmarkl T. Knee function after anterior cruciate ligament ruptures treated conservatively. Int Orthop. 1993;17:208–213. [PubMed]
- Johnson DH, Maffulli N, King JB, Shelbourne KD. Anterior Cruciate Ligament Reconstruction: A Cynical View From the British Isles on the Indications for Surgery. Arthroscopy: The Journal of Arthroscopic and Related Surgery. 2003;19:203–209. [PubMed]
- Moore KL. Essential Clinical Anatomy. 3. Lippincott, Williams, & Wilkins; USA: 2006.
- Spindler KP, Wright RW. Anterior Cruciate Ligament Tear. NEJM. 2008;359:2135–2142.[PMC free article] [PubMed]
- Beynnon BD, Johnson RJ, Abate JA, Fleming BC, Nichols CE. Treatment of Anterior Cruciate Ligament Injuries, Part I. Am J Sports Med. 2005;33:1579–1602. [PubMed]
- Hackett GS, Hemwall GA, Montgomery GA. Ligament and tendon relaxation treated by prolotherapy. 5. Oak Park: Gustav A. Hemwall; 1993.
- Gedney E. The application of sclerotherapy in spondylolisthesis and spondylolysis. The Osteopathic Profession. 1954:66–9. 102–105.
- Linetsky FS, Rafael MF, Saberski L. Pain management with regenerative injection therapy (RIT) In: Weiner RS, editor. Pain Management. Boca Raton: CRC Press; 2002. pp. 381–402.
- Rabago D, Best T, Beamsly M, Patterson J. A systematic review of prolotherapy for chronic musculoskeletal pain. Clinical J Sports Med. 2005;15(5):376–380. [PubMed]
- Dagenais S, Ogunseitan O, Haldeman S, Wooley JR, Newcomb RL. Side effects and adverse events related to intraligamentous injection of sclerosing solutions (prolotherapy) for back and neck pain: a survey of practitioners. Arch Phys Med Rehabil. 2006;87:909–913. [PubMed]
- Maxwell NJ, Ryan MB, Taunton JE, Gillies JH, Wong AD. Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study. Am J Roent. 2007;189(4):W215–220. [PubMed]
- Scarpone M, Rabago D, Zgierska A, Arbogest J, Snell ED. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clinical J Sports Med. 2008;18:248–254. [PMC free article] [PubMed]
- Topol GA, Reeves KD, Hassanein KM. Efficacy of dextrose prolotherapy in elite male kicking-sport athletes with groin pain. Arch Phys Rehabil. 2005;86:697–702. [PubMed]
- Lazzara MA. The non-surgical repair of a complete Achilles tendon rupture by prolotherapy: biological reconstruction. A case report. J Orthopaedic Med. 2005;27:128–132.
- Reeves KD, Hassanein KM. Long-term effects of dextrose prolotherapy for anterior cruciate ligament therapy. Alternative Therapies in Health and Medicine. 2003;9(3):58–62. [PubMed]
- Yelland MJ, Sweeting KR, Lyftogt JA, Ng SK, Scuffham PA. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med. 2009 doi: 10.1136/bjsm.2009.057968. [PubMed] [CrossRef]
- Jensen K, Rabago D, Best TM, Patterson JJ, Vanderby R. Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthop Res. 2008;26:816–823. [PMC free article] [PubMed]
- Micromedex. Morrhuate sodium, Drugdex evaluation. Micromedex Healthcare Series; 2009.
- Liu YK, Tipton CM, Matthes RD, Bedford TG, Maynard JA, Walmer HC. An in-situ study of the influence of a sclerosing solution in rabbit medial collateral ligaments and its junction strength. Connective Tissue Research. 1983;11:95–102. [PubMed]
- Aneja A, Spero G, Weinhold P, et al. Suture plication, thermal shrinkage and sclerosing agents. American Journal of Sports Medicine. 2005;33:1729–1734. [PubMed]
- Banks A. A rationale for prolotherapy. Journal of Orthopaedic Medicine. 1991;13(3):54–59.
- Rabago D, Best TM, Zgierska A, Zeisig E, Ryan M, Crane D. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet rich plasma. BJSM. 2009 doi: 10.1136/bjsm.2008.052761. [PMC free article] [PubMed] [CrossRef]
- Crawford R, Walley G, Bridgman S, Maffulli N. Magnetic resonance imaging versus arthroscopy in the diagnosis of knee pathology, concentrating on meniscal lesions and ACL tears: a systematic review. British Medical Bulletin. 2007;84:5–23. [PubMed]
- Zeiss J. Comparison of bone contusion seen by MRI in partial and complete tears of the anterior cruciate ligament. J Comput Assist Tomogr. 1995;19:773–776. [PubMed]
- Ostrowski JA. Accuracy of 3 diagnostic tests for anterior cruciate ligament tears. J Athl Train. 2006;41:120–121. [PMC free article] [PubMed]